1229 related articles for article (PubMed ID: 16979397)
1. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
[TBL] [Abstract][Full Text] [Related]
2. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice.
Ono M; Ichihara J; Nonomura T; Itakura Y; Taiji M; Nakayama C; Noguchi H
Biochem Biophys Res Commun; 1997 Sep; 238(2):633-7. PubMed ID: 9299565
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
11. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.
Wente W; Efanov AM; Brenner M; Kharitonenkov A; Köster A; Sandusky GE; Sewing S; Treinies I; Zitzer H; Gromada J
Diabetes; 2006 Sep; 55(9):2470-8. PubMed ID: 16936195
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice.
Nonomura T; Tsuchida A; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
Int J Exp Diabetes Res; 2001; 2(3):201-9. PubMed ID: 12369708
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
Garris DR; Garris BL
Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
[TBL] [Abstract][Full Text] [Related]
15. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice.
Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H
Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism.
Hanyu O; Yamatani K; Ikarashi T; Soda S; Maruyama S; Kamimura T; Kaneko S; Hirayama S; Suzuki K; Nakagawa O; Nawa H; Aizawa Y
Diabetes Obes Metab; 2003 Jan; 5(1):27-37. PubMed ID: 12542722
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.
Igarashi R; Nakayama T; Takenaga M; Ichinohe M; Yamaguchi Y; Matsumoto K; Kitagawa A; Nakamura N; Kawai S; Nakagawa T; Taiji M; Nakayama C; Mizushima Y
J Control Release; 2005 Feb; 102(2):463-73. PubMed ID: 15653164
[TBL] [Abstract][Full Text] [Related]
18. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
Nakagawa T; Ogawa Y; Ebihara K; Yamanaka M; Tsuchida A; Taiji M; Noguchi H; Nakao K
Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399
[TBL] [Abstract][Full Text] [Related]
19. Histological, immunocytochemical, and morphometrical analyses of pancreatic islets in the BSB mouse model of obesity.
Slavin BG; Zarow C; Warden CH; Fisler JS
Anat Rec (Hoboken); 2010 Jan; 293(1):108-16. PubMed ID: 19798700
[TBL] [Abstract][Full Text] [Related]
20. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
